The development of fully evolved in situ SCC in Cstc−/− mice, but not in Cstc+/+ mice, suggests that cystatin C deficiency may reduce tumor cell apoptosis and/or increase tumor cell proliferation. This evidence concerns the gene CST3 and neoplasm.